# NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
> **ANDA217735** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2025-09-30
## Drug
- **FDA Application Number:** ANDA217735
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
- **Generic name:** NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE
- **Active ingredients:** HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OTIC
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals NY LLC
- **First approval:** 2025-09-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217735)
---
*AI Analytics · CC0 1.0*